Vikas Agarwal

发表

Location and seed transmission of fungi in discoloured seeds of hybrid rice

M. Pandey, Vachspati Pandey, Vikas Agarwal, 2012 .

Tuberculosis remains a leading contributor to morbidity due to serious infections in Indian patients of SLE

R. Misra, D. Misra, A. Aggarwal, 2023, Clinical rheumatology.

Post-COVID-19 condition in patients with autoimmune rheumatic diseases: the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study

Latika Gupta, R. Aggarwal, A. Nune, 2023, The Lancet Rheumatology.

High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey

M. Hudson, A. Tan, E. Bocci, 2022, Rheumatology International.

Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey

M. Hudson, A. Tan, E. Bocci, 2023, Rheumatology International.

Factors impacting women's advancement to positions on editorial boards of rheumatology journals.

Latika Gupta, P. Ovseiko, T. Khursheed, 2023, Rheumatology.

Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study

C. Caballero-Uribe, A. Tan, E. Bocci, 2023, Rheumatology International.

Overlap syndrome of anti-aquaporin 4 positive neuromyelitis optica spectrum disorder and primary Sjögren's syndrome: a systematic review of individual patient data.

D. Misra, Aman Sharma, G. Naidu, 2023, Rheumatology international.

Long-standing and poorly controlled disease in juvenile dermatomyositis is associated with calcinosis: a real-world experience from a low-middle income country.

R. Misra, D. Misra, Latika Gupta, 2023, Rheumatology international.

Reply to “Letter to the Editor Regarding ‘COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis’”

Latika Gupta, R. Raiker, H. Pakhchanian, 2023, Seminars in Arthritis and Rheumatism.

COVID-19 vaccination in autoimmune diseases (COVAD) Study: vaccine safety and tolerance in rheumatoid arthritis.

M. Hudson, A. Tan, E. Bocci, 2022, Rheumatology.

Coalition for Health and Gender Equity (CHANGE)—a protocol for a global cross-sectional survey of health and gender equity in rheumatology

D. Danda, P. Ovseiko, A. Kalla, 2024, Rheumatology advances in practice.

Angiopoietin-like protein 2 mediates vasculopathy driven fibrogenesis in a mouse model of systemic sclerosis

P. Vemula, D. Saha, Sujaya Thannimangalath, 2023, bioRxiv.

Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey

C. Caballero-Uribe, A. Makol, T. Velikova, 2024, Rheumatology Advances in Practice.

Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group.

C. Caballero-Uribe, A. Makol, T. Velikova, 2024, International journal of rheumatic diseases.

COVID-19 Vaccination-Related Delayed Adverse Events among Patients with Systemic Lupus Erythematosus

W. Katchamart, S. Shaharir, M. Dey, 2023, Journal of clinical medicine.

Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey

O. Distler, A. Makol, T. Velikova, 2023, Rheumatology international.

COVAD survey 2 long-term outcomes: unmet need and protocol

M. Hudson, C. Caballero-Uribe, A. Tan, 2022, Rheumatology International.

Prognostic significance of circulating microparticles in IgA nephropathy.

M. Rai, N. Bharti, Vikas Agarwal, 2023, International urology and nephrology.

COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group

C. Caballero-Uribe, T. Velikova, J. Knitza, 2023, Rheumatology international.

Unravelling the role of Sildenafil and SB204741 in suppressing fibrotic potential of peritoneal fibroblasts obtained from PD patients

S. Chaturvedi, H. Singh, A. Jaiswal, 2024, Frontiers in pharmacology.

Biomarker for Infection in Children with Decompensated Chronic Liver Disease: Neutrophilic CD64 or Procalcitonin?

S. Yachha, U. Poddar, R. Marak, 2024, Clinics And Research in Hepatology and Gastroenterology.

Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohort

A. Makol, E. Nikiphorou, M. Kuwana, 2023, Rheumatology International.

Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study.

C. Caballero-Uribe, W. Katchamart, S. Shaharir, 2024, Rheumatology international.

Listening to patients, for the patients: The COVAD Study—Vision, organizational structure, and challenges

A. Makol, T. Velikova, N. Ziadé, 2024, International journal of rheumatic diseases.

Type 1 diabetes, COVID‐19 vaccines and short‐term safety: Subgroup analysis from the global COVAD study

T. Velikova, Latika Gupta, B. Barman, 2023, Journal of diabetes investigation.

Obstetric Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: An Interview-Based Study in Northern India

L. Andreoli, P. Mehta, R. Kharbanda, 2022, Indian Journal of Rheumatology.